One of our research-peptide clients, in a category with a payment processor scanning every word, no paid channels and manufacturer litigation mid-engagement, reached page one within a week of a push on a $2,999 retainer and reported that sales doubled. He is not a GLP-1 client. What transfers to GLP-1 telehealth is the operating model: find the money already close, keep framing identical everywhere, and plan for a product universe that moves.
What happened, briefly
A research-peptide store with 84% of its organic traffic on one product page and a flagship blend sitting at position 37 for a 26,000-search term. Inside the first month we pushed that page; it reached page one within a week of the push. The client reported that sales doubled and that one order alone was worth about $3,400. The page-one hold was temporary; the page sits in the top 15 today. The full account with dates and limitations is on our peptide practice's site: the case study on PeptidesSEO.
What transfers
- Find money first. GLP-1 telehealth sites also have pages sitting at 11 to 30 for comparison, cost and programme queries. They move before any new content does.
- Framing consistency. The peptide litigation turns on marketing that contradicted the label. FDA's telehealth letters turn on website copy that contradicted the product's status. Same failure mode, different regulator.
- A product universe that moves. One compound was frozen by litigation in August; the plan moved to the replacement revenue driver. Compounded GLP-1 availability has moved three times in eighteen months. The plan has to be built for it.
- Three readers per page. Google, a scanner or regulator, and the customer. Wording is a ranking and a risk decision at once.
What does not transfer
- The competitive field. Peptide vendors rank at modest authority; GLP-1 head terms are held by pharmacies and platforms. The GLP-1 plan leans harder on comparison, cost, state and brand demand.
- The claims rulebook. Research-use-only vocabulary rules do not apply to a prescribing telehealth programme, which has its own.
- The numbers. A peptide result says nothing about what a GLP-1 programme will do. Results are individual, dated and reported as stated.
Related
GLP-1SEO provides search-marketing services and publishes search-marketing analysis. We are not physicians, pharmacists, lawyers or regulatory consultants, and nothing on this site is medical, legal or regulatory advice, or advice to patients. Clients remain responsible for obtaining qualified advice about their products, claims, jurisdictions and operations.